[2Pa] Neurodegenerative Disorders

[2Pa-105] Specific administration of a novel anti-IL-18 antibody during effector phase improves EAE

○Yuki Nakashima¹, Hisao Miyajima¹, Shota Sasaki¹, Huy Xuan Ngo², Yoshinori Otani¹, Masashi Fujitani¹ (1. Department of Anatomy and Neuroscience, Faculty of Medicine, Shimane University, 2. Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Shimane University)

Keywords:Multiple sclerosis, EAE, IL-18